Investigational drug NG004 for recent spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests a new drug called NG004 given by injection around the spinal cord. It aims to help people with recent incomplete spinal cord injuries recover function. The drug is given within the first month after injury and may be an option for those who meet the health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a spinal cord injury in the neck area (between the C1 and C8 vertebrae) that is incomplete, meaning some function remains below the injury.
- Your injury happened between 4 and 28 days before the study starts, and at least 4 days after any spinal surgery.
- You do not require a breathing machine (ventilator) or only need it partially.
- You are stable enough from a heart and general health standpoint.
- You have not had certain other serious conditions (like significant head injury, multiple sclerosis, recent infection around the spine, or a history of severe allergic reactions).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a spinal cord stimulation approach plus rehab can improve function and safety in people with an incomplete spinal cord injury who cannot walk. It may help people by supporting rehabilitation over time, but it requires surgery and specific health and imaging conditions.
This trial tests an experimental pill for people with spinal cord injury who have long-term nerve pain. It aims to see if the drug can reduce pain and be safe.
This study tests whether surgery to take pressure off the spinal cord, plus placing a small nerve graft, can help recovery after a severe spinal cord injury. It is for people with a recent injury who have lost all movement and feeling below the level of injury.
This trial studies how nerve pathways in the spinal cord help control movements in people with spinal cord injury. It may help researchers better understand movement control and could lead to improved rehab strategies.
This trial tests an implanted nerve stimulation approach to help people with certain spinal cord injuries regain more voluntary movement. It may help if your injury pattern and MRI findings suggest there are still usable nerve fibers that can be targeted.
This trial tests a new medicine called NVG-291 for people with chronic spinal cord injury (1-10 years) in the neck area who still have some movement. The study aims to see if the drug can help improve arm and leg function.
Hear when a new Acute Spinal Cord Injury (SCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.